Therefore, to extend the support for the physiological relevance and anti-inflammatory nature of the identified IL2-AIS, we examined the signature in a well-established inflammatory context in COVID-19 patients, using the COMBAT and INCOV datasets (Fig. 1A). The gene discussed is IL2; the disease is COVID-19.